GLP-1 drugs show promise in chronic conditions beyond diabetes, obesity, and heart disease including liver disease, chronic kidney disease, and obstructive sleep apnea
Elevated cortisol shifts hair follicles from anagen to catagen, accelerating the progression toward telogen
(GLP-1 stands for glucagon-like peptide-1 and is a hormone produced within the digestive system and in parts of the brain after we eat.) Patients and clinicians soon realized their powerful weight-loss effects: Semaglutide (a.k.a
Patients frequently report diminished hunger, quicker satiety during meals, reduced cravings, increased energy for activities, and improvements in key metrics like blood pressure and cholesterol
This distinction is particularly relevant for clinical practice, as REWIND demonstrated benefits in patients at moderate cardiovascular risk without previous events
Mol Carcinog 4(3):196202 Pollock PM, Harper UL, Hansen KS, Yudt LM, Stark M, Robbins CM, Moses TY, Hostetter G, Wagner U, Kakareka J, Salem G, Pohida T, Heenan P, Duray P, Kallioniemi O, Hayward NK, Trent JM, Meltzer PS (2003) High frequency of BRAF mutations in nevi
